| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |